SS Innovations International (NASDAQ: SSII) Indian Surgical Robotics Growth Points to Broader Market Opportunity IBN.ai

SS Innovation’s SSi Mantra system was used in more than 50 robotic surgeries in a single day at Mohak Bariatrics and Robotics in Indore, highlighting growing clinical utilization in India.
The milestone comes as SS Innovations reports 224 SSi Mantra systems installed across 12 countries, providing a growing installed base for future procedure and instrument revenue.
Second-quarter 2026 installations reached 30 systems, above the 25 systems modeled by the analyst cited in the supplied report.
Quarterly revenue reached $13.9 million, up 39% year over year, while system sales increased 41% to $12.4 million.
FDA review of the SSi Mantra 510(k) application is now expected by the end of the first quarter of 2027, while European CE marking remains targeted for the end of 2026.
The company’s progress in India gives it a major commercial base while it pursues entry into the U.S. and European surgical robotics markets.

SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, is gaining another indication of the scale that its SSi Mantra surgical robotic system can support in India, where more than 50 robotic procedures were performed in a single day at Mohak Bariatrics and Robotics in Indore.

The milestone, announced by SS Innovations on LinkedIn, came on India’s 80th Independence Day and involved procedures conducted under the leadership of Dr. Mohit Bhandari. The event is notable less for the headline number than for what it demonstrates about the potential utilization of robotic surgery in a large healthcare market where adoption is still…

SS Innovations International (NASDAQ: SSII) Indian Surgical Robotics Growth Points to Broader Market Opportunity

SS Innovations International (NASDAQ: SSII) Indian Surgical Robotics Growth Points to Broader Market Opportunity